Anna Rowland is a Principal Scientist at Cerevance, where they have worked since 2020, following roles as Senior Scientist and Research Scientist. They previously held a position as a Research Scientist at Takeda and served as an Undergraduate ADMET Scientist at Evotec. Anna earned a Bachelor of Science in Natural Sciences with First Class Honours from the University of Bath and completed a Ph.D. in Antifungal Drug Discovery at the University of Manchester, where their research focused on novel drug targets within the fungal pathogen Aspergillus fumigatus.
This person is not in any teams
This person is not in any offices